MAP Kinase p38Inhibitors: Clinical Results and an Intimate Look at Their Interactions with p38 Protein

E-ISSN： 1875-533x|12|25|2979-2994

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.12, Iss.25, 2005-12, pp. : 2979-2994

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pyridinylimidazole Based p38 MAP Kinase Inhibitors

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 9, 2002-09 ,pp. : 1011-1020

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of p38 kinase

By Hanson G.J.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 7, 1997-07 ,pp. : 729-733

Informa Healthcare

Access to resources Recommend Favorite

The Non-Diaryl Heterocycle Classes of p38 MAP Kinase Inhibitors

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 9, 2002-09 ,pp. : 1021-1035

Bentham Science Publishers

Access to resources Recommend Favorite

p38 MAP Kinase Inhibitors as Potential Therapeutic Drugs for Neural Diseases

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 11, Iss. 1, 2011-03 ,pp. : 45-59

Bentham Science Publishers

Access to resources Recommend Favorite

Successful Structure-Based Design of Recent p38 MAP Kinase Inhibitors

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 7, 2009-05 ,pp. : 655-676

Bentham Science Publishers

Access to resources Recommend Favorite